Inventors with similar research interests:
Company Filing History:
26 out of 50 
11 out of 36 
10 out of 44 
Years Active: 2010-2024
Title: Özlem Türeci: Revolutionizing Cancer Treatment with mRNA Technology
Introduction:
In the realm of biotechnology and medical research, Özlem Türeci is a prominent figure co-founding BioNTech, an innovative company dedicated to developing personalized cancer immunotherapies and mRNA-based vaccines. Together with her husband, Dr. Uğur Şahin, and Christoph Huber, Türeci has spearheaded groundbreaking advancements in the field. Her contributions have been instrumental in the development of BioNTech's mRNA technology platform, which garnered global recognition during the COVID-19 pandemic.
Latest Patents:
Özlem Türeci's remarkable aptitude for innovation is evident in her extensive patent portfolio. With a total of 49 patents, she has made significant contributions to cancer treatment methodologies. Two of her most recent patents include:
1. Antibodies specific for claudin 6 (CLDN6): This invention provides antibodies that have proven effective as therapeutics for treating and preventing diseases associated with cells expressing Claudin-6 (CLDN6). These antibodies hold tremendous potential for various tumor-related diseases, such as ovarian cancer, lung cancer, gastric cancer, breast cancer, pancreatic cancer, and more.
2. Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2 and CD3 for treatment of Claudin expressing cancer diseases: This patent involves the development of binding agents comprising three binding domains. The first domain binds to a T cell-specific antigen, while the second and third domains bind to a claudin. This unique approach offers promising treatment options for cancers expressing Claudin-6 or Claudin-18.2.
Career Highlights:
Özlem Türeci's professional journey encompasses notable achievements that have shaped the landscape of cancer immunotherapy. Alongside her co-founder roles at BioNTech, she has held positions in renowned companies such as Ganymed Pharmaceuticals AG and Biontech AG. These experiences have allowed her to refine her expertise and remain at the forefront of groundbreaking discoveries in the field.
Collaborations:
Throughout her career, Türeci has collaborated closely with esteemed colleagues, including Dr. Uğur Şahin and Michael Koslowski. These collaborations have been invaluable in translating scientific advancements into tangible breakthroughs. By fostering a collaborative spirit, Türeci has harnessed the collective genius of her peers to drive innovation and change the landscape of cancer treatment.
Conclusion:
Özlem Türeci's contributions to the field of biotechnology and cancer immunotherapy are truly exceptional. Through her co-founding role at BioNTech and her involvement in various companies, she has spearheaded the development of innovative mRNA-based technologies that have redefined cancer treatment possibilities. With an impressive patent portfolio and a relentless dedication to improving patient outcomes, Türeci is a trailblazer who continues to shape the future of personalized medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.